Epidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy

By Giaccone Giuseppe   Iacona Renee   Fandi Abderrahim   Janas Mette   Ochs Judith   Herbst Roy   Johnson David  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 3, 2009-03 ,pp. : 467-476

Springer Publishing Company

Access to resources Recommend Favorite

Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib

By                              

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 802-806

Science Publishers

Access to resources Recommend Favorite

Epidermal growth factor receptor mutations predict sensitivity to gefitinib in patients with non-small-cell lung cancer

By Riedel Richard F   Febbo Phillip G  

Future Oncology, Vol. 1, Iss. 4, 2005-08 ,pp. : 461-466

Future Medicine

Access to resources Recommend Favorite

Epidermal growth factor receptor gene amplification and gefitinib sensitivity in patients with recurrent lung cancer

By Sasaki Hidefumi   Endo Katsuhiko   Okuda Katsuhiro   Kawano Osamu   Kitahara Naoto   Tanaka Hisaichi   Matsumura Akihide   Iuchi Keiji   Takada Minoru   Kawahara Masaaki   Kawaguchi Tomoya   Yukiue Haruhiro   Yokoyama Tomoki   Yano Motoki   Fujii Yoshitaka  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 5, 2008-05 ,pp. : 569-577

Springer Publishing Company

Access to resources Recommend Favorite

Elevated serum levels of TPS and CYFRA 21-1 predict poor prognosis in advanced non-small-cell lung cancer patients treated with gefitinib

By Chen Fengsheng   Luo Xi   Zhang Jinbiao   Lu Yang   Luo Rongcheng  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 950-957

Humana Press, Inc

Access to resources Recommend Favorite